HUP0304050A2 - Módosított FVII az ARDS kezelésre - Google Patents

Módosított FVII az ARDS kezelésre

Info

Publication number
HUP0304050A2
HUP0304050A2 HU0304050A HUP0304050A HUP0304050A2 HU P0304050 A2 HUP0304050 A2 HU P0304050A2 HU 0304050 A HU0304050 A HU 0304050A HU P0304050 A HUP0304050 A HU P0304050A HU P0304050 A2 HUP0304050 A2 HU P0304050A2
Authority
HU
Hungary
Prior art keywords
ards
treatment
modified fvii
medicament
humans
Prior art date
Application number
HU0304050A
Other languages
English (en)
Inventor
Mirella Ezban
Steven Idell
Claude A. Piantadosi
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of HUP0304050A2 publication Critical patent/HUP0304050A2/hu
Publication of HUP0304050A3 publication Critical patent/HUP0304050A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány módosított faktor VII gyógyszer gyártáshoz történőhasználatával foglalkozik, mellyel az akut tüdősérülést és az akutlégzési rendellenesség szindrómát (ARDS) kezelheti emberekben. Ó
HU0304050A 2001-05-02 2002-05-01 Modified fvii in treatment of ards HUP0304050A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100692 2001-05-02
PCT/DK2002/000279 WO2002087605A2 (en) 2001-05-02 2002-05-01 Modified fvii in treatment of ards

Publications (2)

Publication Number Publication Date
HUP0304050A2 true HUP0304050A2 (hu) 2004-03-29
HUP0304050A3 HUP0304050A3 (en) 2005-12-28

Family

ID=8160467

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0304050A HUP0304050A3 (en) 2001-05-02 2002-05-01 Modified fvii in treatment of ards

Country Status (12)

Country Link
US (1) US20040033200A1 (hu)
EP (1) EP1385535A2 (hu)
JP (1) JP2004527554A (hu)
KR (1) KR20040094288A (hu)
CN (1) CN1522151A (hu)
AU (1) AU2002338487A1 (hu)
CA (1) CA2445811A1 (hu)
HU (1) HUP0304050A3 (hu)
IL (1) IL158615A0 (hu)
PL (1) PL366564A1 (hu)
RU (1) RU2003134701A (hu)
WO (1) WO2002087605A2 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109680A1 (en) * 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) * 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
AU5807500A (en) 1999-07-14 2001-02-05 Novo Nordisk A/S Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis
KR100912381B1 (ko) * 2003-06-19 2009-08-19 타녹스 인코퍼레이티드 응고 관련 질병을 치료하기 위한 조성물 및 방법
ES2381110T3 (es) 2003-09-09 2012-05-23 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación
JP2008515908A (ja) * 2004-10-06 2008-05-15 ユニバーシティー オブ ロチェスター 組織因子経路を阻害する薬剤を使用する、肺高血圧症の治療
US8088728B2 (en) * 2005-06-24 2012-01-03 Drugrecure Aps Airway administration of tissue factor pathway inhibitor in inflammatory conditions affecting the respiratory tract
US20110142837A1 (en) * 2007-07-20 2011-06-16 Trustees Of The University Of Pennsylvania Method Of Treating Acute Respiratory Distress Syndrome
US8251876B2 (en) * 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3459416B2 (ja) * 1991-02-28 2003-10-20 ザイモジェネティクス，インコーポレイティド 修飾されたファクター▲ｖｉｉ▼
US5833982A (en) * 1991-02-28 1998-11-10 Zymogenetics, Inc. Modified factor VII
US5997864A (en) * 1995-06-07 1999-12-07 Novo Nordisk A/S Modified factor VII
DE60014919T2 (de) * 1999-08-06 2005-10-13 Genentech, Inc., South San Francisco Peptidantagonisten des faktors viia
IL162618A0 (en) * 2001-12-21 2005-11-20 Novo Nordisk As Liquid composition of modified factor vii polypeptides

Also Published As

Publication number Publication date
CA2445811A1 (en) 2002-11-07
PL366564A1 (en) 2005-02-07
IL158615A0 (en) 2004-05-12
JP2004527554A (ja) 2004-09-09
KR20040094288A (ko) 2004-11-09
CN1522151A (zh) 2004-08-18
WO2002087605A2 (en) 2002-11-07
EP1385535A2 (en) 2004-02-04
AU2002338487A1 (en) 2002-11-11
HUP0304050A3 (en) 2005-12-28
US20040033200A1 (en) 2004-02-19
WO2002087605A3 (en) 2003-01-03
RU2003134701A (ru) 2005-03-27

Similar Documents

Publication Publication Date Title
HUP0301447A2 (hu) Tiotrópium- és salmeterolsókat tartalmazó kombinációs gyógyszerkészítmények
NL300933I2 (nl) Letermovir
MXPA03005340A (es) Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida.
IL169897A0 (en) Sustituted heterocycles
UA85574C2 (uk) Ендопаразитоцидний засіб для місцевого застосування
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
NO20050063L (no) 2-heteroaryl karboksamider
EE200400059A (et) Diarüültsükloalküülderivaadid, nende kasutamine ravimite valmistamiseks ning neid sisaldav ravim
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
SE0303571D0 (sv) Medical product for moisture-sensitive medicaments
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
HUP0304050A2 (hu) Módosított FVII az ARDS kezelésre
TW200621799A (en) Acylated nonadepsipeptides II
HUP0400976A2 (hu) VII-es faktor polipeptideket és XI-es faktor polipeptideket tartalmazó gyógyszerészeti összetételek
HUP0200475A2 (hu) Perfluor-alkil-amidok, azok előállítása, és diagnosztikai alkalmazása
HUP0302233A2 (hu) Virális betegségek kezelésére IL-18-cal és IL-18 kombinációkkal
WO2007057436A3 (en) Interferon in influenza
NO20032597L (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
HUP0402298A2 (hu) Dezoxipeganin alkalmazása klinikai depresszió kezelésére
HUP0402131A2 (hu) Szinergetikus hatású pirimetanilt és iprodiont tartalmazó fungicid készítmény és alkalmazása
EA200501625A1 (ru) Интерферон-бета при тяжелом остром респираторном синдроме (sars)
HUP0300876A2 (hu) Diklofenaksók alkalmazása égési sérülések helyi kezelésére használható gyógyszerkészítmény előállítására
DE60222669D1 (de) Asthma-assoziiertes gen

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees